Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy in transplantation.

K J Wood1, T G Prior

  • 1Nuffield Department of Surgery, University of Oxford, John Radcliffe Hospital, Headington, UK. kathryn.wood@nds.ox.ac.uk

Current Opinion in Molecular Therapeutics
|August 30, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ex vivo-expanded human CD19<sup>+</sup>TIM-1<sup>+</sup> regulatory B cells suppress immune responses in vivo and are dependent upon the TIM-1/STAT3 axis.

Nature communications·2022
Same author

Quantification of CD4(+) T Cell Alloreactivity and Its Control by Regulatory T Cells Using Time-Lapse Microscopy and Immune Synapse Detection.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
Same author

Demethylation of the TSDR is a marker of squamous cell carcinoma in transplant recipients.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2014
Same author

Harnessing regulatory T cells for clinical use in transplantation: the end of the beginning.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2014
Same author

The role of donor-specific HLA alloantibodies in liver transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2014
Same author

Cross-validation of IFN-γ Elispot assay for measuring alloreactive memory/effector T cell responses in renal transplant recipients.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2013

Gene therapy offers promising strategies to enhance organ transplant success by enabling local production of protective molecules. This approach aims to improve graft survival and reduce side effects, potentially revolutionizing transplantation medicine.

Area of Science:

  • Immunology
  • Regenerative Medicine
  • Transplantation Science

Background:

  • Gene therapy strategies are crucial for prolonging graft survival in transplantation.
  • Local production of immunosuppressive molecules can minimize systemic side effects and enhance therapeutic efficiency.
  • Ex vivo gene transfer allows for pre-engraftment manipulation of cells.

Purpose of the Study:

  • To explore the potential of gene therapy in improving outcomes for organ transplantation.
  • To highlight advancements in gene transfer vectors and their applications.
  • To discuss novel approaches like suicide gene therapy and stem cell gene transfer for tissue repair.

Main Methods:

  • Utilizing gene transfer to express immunomodulatory and graft-protecting molecules.

Related Experiment Videos

  • Employing ex vivo gene transfer for pre-engraftment manipulation.
  • Developing advanced vectors for efficient gene delivery to various cells, tissues, and organs.
  • Implementing suicide gene therapy systems for time-controlled elimination of genetically modified cells.
  • Investigating gene transfer to stem cells for tissue repair and regeneration.

    • Main Results:

    • Gene transfer enables local production of immunosuppressive molecules, increasing bioavailability and therapeutic efficiency.
    • Advanced vectors facilitate optimal gene transfer to diverse cellular and tissue targets.
    • Suicide gene therapy offers controlled elimination of modified cells.
    • Stem cell gene transfer shows potential for accelerated tissue repair and regeneration.

    Conclusions:

    • Gene therapy presents a powerful tool to enhance graft survival and reduce complications in transplantation.
    • Innovations in gene transfer technology and strategies like suicide gene therapy and stem cell applications hold significant promise for the future of transplantation.
    • Emerging techniques such as xenotransplantation and organ cloning may address donor organ shortages.